Latest News about XNAS:UNCY
Recent news which mentions XNAS:UNCY
   Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) - October 14, 2025 Deadline to Join - Contact Levi & Korsinsky
   
  August 27, 2025
  Tickers 
   UNCY
  
  
  
 
   Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
   
  August 26, 2025
  Tickers 
   UNCY
  
  
  
 
   Kaplan Fox Alerts Unicycive Therapeutics, Inc. (UNCY) Investors to a Securities Class Action Lawsuit - Deadline is October 14, 2025
   
  August 26, 2025
  Tickers 
   UNCY
  
  
  
 
   Shareholders of Unicycive Therapeutics, Inc. Should Contact Levi & Korsinsky Before October 14, 2025 to Discuss Your Rights - UNCY
   
  August 25, 2025
  Tickers 
   UNCY
  
  
  
 
   Kaplan Fox & Kilsheimer LLP is Investigating Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations
   
  June 30, 2025
  Tickers 
   UNCY
  
  
  
 
   Kaplan Fox Alerts Investors of Unicycive Therapeutics to an Investigation of Possible Securities Law Violations
   
  June 13, 2025
  Tickers 
   UNCY
  
  
  
 
   Kaplan Fox is Investigating Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations
   
  June 11, 2025
  Tickers 
   UNCY
  
  
  
 
   Kaplan Fox Announces an Investigation Into Unicycive Therapeutics, Inc. (UNCY) for Potential Securities Law Violations
   
  June 10, 2025
  Tickers 
   UNCY
  
  
  
 
   The Unmet Need For Innovative And Effective Treatments For Kidney Disease: Acute Kidney Injury
   
  March 07, 2023
  Tickers 
   UNCY
  
  
  
 Tickers 
   UNCY
  
  
  
 
   Unicycive: The Company Developing Key Kidney Therapies
   
  February 17, 2023
  Tickers 
   UNCY
  
  
  
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.